Retour sur lavenir.net
   UMICORE 22.520 € (+1,99 %)     ARGENX SE 813.000 € (+2,14 %)     CENERGY 25.000 € (-5,87 %)     LOTUS BAKERIES 11 060.000 € (-0,18 %)     SYENSQO 65.300 € (-1,58 %)     AGEAS 68.900 € (+0,07 %)     KINEPOLIS GROUP 35.500 € (+0,42 %)     KBC ANCORA 83.000 € (0,00 %)     ACKERMANS V.HAAREN 287.800 € (-0,83 %)     GIMV 44.800 € (+0,79 %)     BARCO 8.475 € (-1,45 %)     MELEXIS 81.250 € (-4,41 %)     OXURION 0.003 € (-5,88 %)     COFINIMMO 80.600 € (-0,49 %)     CMB.TECH 13.860 € (+5,00 %)     INCLUSIO SA/NV 16.600 € (-1,19 %)     ACCENTIS 0.027 € (0,00 %)     BPOST 1.578 € (0,00 %)     ECONOCOM GROUP 1.530 € (-1,29 %)     COLRUYT 34.380 € (+0,53 %)     WHAT'S COOKING GP 145.000 € (0,00 %)     IMMOBEL 22.200 € (-5,13 %)     AGFA-GEVAERT 0.432 € (-0,58 %)     ONTEX GROUP 2.415 € (+0,21 %)     BREDERODE 102.000 € (-1,16 %)     QRF 11.150 € (-0,45 %)     BIOTALYS 3.155 € (-1,10 %)     SOLVAY 27.100 € (-1,38 %)     FAGRON 24.050 € (-0,41 %)     ONWARD MEDICAL 2.680 € (+1,52 %)     NYXOAH 1.434 € (+1,56 %)     DECEUNINCK 2.220 € (-3,48 %)     CARE PROPERTY INV. 12.520 € (+0,32 %)     BANQUP GROUP 2.320 € (-2,52 %)     IBA 16.100 € (-0,98 %)     HOME INVEST BE. 19.100 € (-1,44 %)     XIOR 26.000 € (-0,57 %)     MATERIALISE 5.750 € (0,00 %)     FLUXYS BELGIUM D 20.400 € (+3,03 %)     RETAIL ESTATES 69.500 € (0,00 %)     TUBIZE-FIN 215.400 € (+0,37 %)     VASTNED 29.450 € (-0,84 %)     UCB 251.700 € (+1,66 %)     VAN DE VELDE 30.200 € (+0,33 %)     JENSEN-GROUP 82.000 € (-3,98 %)     DEME GROUP 181.800 € (-0,98 %)     TESSENDERLO 19.880 € (-1,58 %)     TINC 11.680 € (0,00 %)     CIE BOIS SAUVAGE 296.000 € (-1,00 %)     AEDIFICA 68.550 € (-0,44 %)     VGP 80.100 € (-1,84 %)     AZELIS GROUP 9.585 € (-2,09 %)     AB INBEV 72.200 € (+1,92 %)     EVS 28.200 € (0,00 %)     D'IETEREN GROUP 165.900 € (+0,48 %)     ELIA GROUP 135.600 € (-0,29 %)     GBL 78.800 € (-0,94 %)     SOFINA 220.200 € (-2,74 %)     CAMPINE 224.000 € (-1,75 %)     TITAN S.A. 53.050 € (-1,21 %)  
   ADYEN 833.000 € (-4,71 %)     AIR LIQUIDE 166.440 € (+0,45 %)     AEGON 7.550 € (0,00 %)     STMICROELECTRONICS 63.470 € (-8,53 %)     ALSTOM 16.175 € (-0,22 %)     ING GROEP N.V. 27.915 € (-0,92 %)     COMPAGNIE ODET 1 490.000 € (-0,13 %)     IPSEN 162.600 € (+3,44 %)     ARKEMA 57.200 € (-1,21 %)     LINEDATA SERVICES 40.500 € (-2,41 %)     L'OREAL 376.000 € (-0,56 %)     TOTALENERGIES 70.810 € (-0,16 %)     ORANGE 16.905 € (+0,24 %)     ASML HOLDING 1 560.800 € (-5,74 %)     STELLANTIS NV 5.273 € (-6,66 %)     LVMH 483.700 € (+0,49 %)     CRCAM BRIE PIC2CCI 36.690 € (-0,05 %)     THALES 228.000 € (+0,75 %)     KEYRUS 8.140 € (+9,70 %)     RELX 27.260 € (+0,81 %)     REXEL 37.130 € (-3,26 %)     GENFIT 11.020 € (+2,80 %)     TOUR EIFFEL 8.120 € (-0,25 %)     EXOR NV 64.700 € (-2,27 %)     BOLLORE 4.010 € (+2,82 %)     HEINEKEN 72.560 € (+2,20 %)     VALLOUREC 22.230 € (-0,18 %)     THX PHARMA 3.320 € (+0,91 %)     HAL TRUST 164.000 € (-0,24 %)     SCHNEIDER ELECTRIC 279.500 € (-4,53 %)     AHOLD DEL 34.850 € (+1,81 %)     SIGNIFY NV 17.830 € (-14,77 %)     QUADIENT 12.140 € (+0,50 %)     EXAIL TECHNOLOGIES 102.800 € (-1,15 %)     PROSUS 36.955 € (-2,38 %)     ACOMO 22.700 € (+0,44 %)     VINCI 129.100 € (-1,19 %)     ASM INTERNATIONAL 994.000 € (-7,88 %)     KPN KON 4.373 € (+0,28 %)     CEGEDIM 11.400 € (-0,87 %)     DASSAULT AVIATION 296.600 € (+1,23 %)     ESSILORLUXOTTICA 168.150 € (-0,21 %)     CRCAM NORD CCI 29.990 € (-0,43 %)     SOLUTIONS 30 SE 0.667 € (-0,74 %)     INPOST 15.350 € (-0,13 %)     BOUYGUES 50.020 € (-0,79 %)     SOITEC 120.400 € (-6,99 %)     SAFRAN 331.100 € (-0,03 %)     BAM GROEP KON 12.340 € (-0,88 %)     ARCELORMITTAL SA 55.840 € (+0,61 %)     PHILIPS KON 23.410 € (-1,14 %)     BUREAU VERITAS 25.740 € (+0,78 %)     APERAM 46.760 € (-0,13 %)     MICHELIN 32.670 € (-2,10 %)     2CRSI 27.620 € (+25,55 %)     ADP 110.200 € (-0,90 %)     CRCAM LANGUED CCI 97.030 € (+0,03 %)     DERICHEBOURG 10.050 € (+0,60 %)     KAUFMAN ET BROAD 24.000 € (-0,83 %)     ACCOR 49.020 € (+1,30 %)  
News Réglementées
17/06/2026 09:00

Original-Research: GFT Technologies SE (von NuWays AG): BUY

Original-Research: GFT Technologies SE - from NuWays AG

17.06.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to GFT Technologies SE

Company Name:GFT Technologies SE
ISIN:DE0005800601
 
Reason for the research:Update
Recommendation:BUY
Target price:EUR 32
Target price on sight of:12 months
Last rating change:
Analyst:Simon Keller

Banking IT remains a specialist game

We hosted GFT at our London conference, which reinforced the key pillars of the equity story:
  • Quality remains the bedrock. GFT is a banking specialist in one of the hardest IT verticals, where security, regulation and legacy stacks make execution risk the real cost. Quality leadership in digital banking is externally validated (e.g. IDC and QKS), and the client roster speaks for itself, with Deutsche Bank, HSBC, JPM and Santander among them. While the business does not generate recurring revenue by design, relationships are very sticky due to trust and system knowledge: once GFT has done a complex project it is deeply embedded in the client's IT estate, which makes it hard to displace. Consistently high utilisation points to disciplined capacity management and supports the margin resilience of the model.
  • The market is large and still growing, although a broad-based pick-up is not yet visible in group-reported numbers, partly masked by the struggling UK business. With approx. 75% of banks still running on legacy systems, there remains a sizeable market opportunity in banking IT modernisation, expected to result in a market CAGR of c. 18% into 2030 (source: Mordor Intelligence). This is not a one-to-one read-through to GFT sales, yet the need for integration, data flows, APIs and core platform work fits GFT’s capabilities well. AI should act as a demand multiplier, shifting the bottleneck to precisely those areas.
  • AI looks net accretive on balance. While prices per project decline thanks to efficiencies, volume growth is seen to more than offset this effect, as more projects clear the ROI hurdle and clients broaden the scope. GFT's proprietary Wynxx platform, mainly a project enabler, is more than a wrapper around individual LLMs. Its model-agnostic setup routes tasks across ChatGPT, Claude, Gemini, proprietary and open-source models based on cost, speed, capability, security and use case. The value-add lies in GFT’s orchestration know-how and preconfigured agents, making AI deployable in complex enterprise IT environments. At Bradesco Seguros, the client reinvested efficiency gains into additional scope, following intense Wynxx testing, lifting revenue above pre-Wynxx levels for GFT. Similarly, a Brazilian automotive group's documentation programme, uneconomical pre-AI at c. 1.5 years and $ 1.1m, was reframed into a 16-week, $ 100k delivery, turning it into incremental revenue.
  • Margins are set to expand, and Q1 already showed the first signs, with the adj. EBIT margin up 0.2pp yoy to 7%. Two levers are seen to support the remaining quarters. The first is the UK turnaround: we expect the unit to return to profitability in Q2 and to resume growth in Q3, following capacity rightsizing, new leadership and an improving pipeline. Second, strategic mid-term initiatives: smartshore should scale to 40% by 2029 from c. 20%, while high-value-added services should increase from c. 25% today to up to 50%, supported by bolt-on M&A such as Megawork (closed in Sep 25).
  • Guidance remains for c. 5% fx-adj. growth and a slight EBT margin improvement to 6% (+0.8pp yoy), which appears achievable without any meaningful market recovery.
BUY, PT € 32, based on DCF.

You can download the research here: gft-technologies-se-2026-06-17-update-en-95350
For additional information visit our website: https://www.nuways-ag.com/research

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2347616  17.06.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière